SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

VNDA

Vanda Pharmaceuticals Inc.
NASDAQHealth Care

Latest close: 4.03 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 6, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  2. Aug 5, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Jun 5, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record1,25912 flagged findings
Reported transactions (Form 4)56since Feb 16, 2023 · and 10 other holdings
Corporate events (8-K)30since Mar 1, 2018

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 1,259)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 9, 26SCHEDULE 13G/A ↗Passive stake · Millennium Management LLC · 7.0% · event on Sep 30, 26 · amendment
  • Aug 19, 26SCHEDULE 13G ↗Passive stake · Millennium Management LLC · 5.6% · event on Aug 17, 26
  • Aug 13, 26SCHEDULE 13G ↗Passive stake · AQR Capital Management, LLC · 5.8% · event on Jun 30, 26
  • Aug 6, 2610-Q ↗Quarterly report
  • Aug 5, 268-K ↗Current report · Results
  • Insider transaction · 7 Form 4 filingsshow all 7hide
  • Jun 8, 26Form 3 ↗Insider transaction
  • Jun 5, 268-K ↗Current report · Shareholder vote results
  • May 20, 26Form 4 ↗Insider transaction
  • May 12, 26SCHEDULE 13G ↗Passive stake · STATE STREET CORPORATION · 5.1% · event on Mar 31, 26
  • May 7, 2610-Q ↗Quarterly report
  • May 6, 268-K ↗Current report · Results
  • Apr 29, 26SCHEDULE 13G/A ↗Passive stake · BlackRock Portfolio Management LLC · 4.2% · event on Mar 31, 26 · amendment
  • Apr 24, 26Form 4 ↗Insider transaction
  • Apr 24, 26Form 3 ↗Insider transaction
  • Apr 24, 26CORRESP ↗Correspondence with the SEC
  • Apr 23, 26DEFA14A ↗Shareholder meeting and votes
  • Apr 23, 26DEF 14A ↗Shareholder meeting and votes
  • Apr 22, 268-K ↗Current report · A senior executive left or was appointed

1,259 filings on record, the oldest from Apr 12, 06.

Listing the 25 most recent filings of the 1,259 on record.

8-Ks, explained

Stress1Structure30Governance51
  • Governance4 senior executive changes2025 – 2026show all 4hide
    • Apr 22, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Apr 2, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Feb 19, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Feb 20, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Structure3 material agreements entered2024show all 3hide
    • Aug 8, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • May 3, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Apr 17, 24StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Feb 21, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Dec 7, 23StructureCompleted an acquisition or disposal+3 more in the same filing8-K 2.01 ↗
  • Governance3 senior executive changes2022 – 2023show all 3hide
    • Mar 17, 23GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Feb 17, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Mar 1, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jan 14, 22StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Governance10 senior executive changes2019 – 2021show all 10hide
    • Oct 8, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Feb 25, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jul 29, 20GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Mar 3, 20GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Feb 20, 20GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Feb 19, 20GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Jan 21, 20GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Oct 28, 19GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Apr 24, 19GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Mar 1, 19GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jun 1, 18StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Apr 25, 18GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Apr 23, 18GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Mar 16, 18StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Mar 1, 18GovernanceA senior executive left or was appointed8-K 5.02 ↗

The record reaches back to Jul 7, 06.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Dec 17, 08StressRestructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗

The full record holds 1 stress filing.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • BlackRock, Inc.8.1%Jan 31, 25SCHEDULE 13G/A ↗1 earlier filing
  • Millennium Management LLC7.0%Sep 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
  • AQR Capital Management, LLC5.8%Jun 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • STATE STREET CORPORATION5.1%Mar 31, 26SCHEDULE 13G ↗
  • BlackRock Portfolio Management LLC4.2%Mar 31, 26SCHEDULE 13G/A ↗2 earlier filings

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Mar 2, 26Sell$1.3MMihael Hristos PolymeropoulosPresident and CEO↗
  • Mar 2, 26Sell$351KGunther BirznieksSVP, Business Development↗
  • Mar 2, 26Sell$351KTimothy WilliamsSVP & General Counsel↗
  • Mar 2, 26Sell$255KJoakim WijkstromSVP, Chief Marketing Officer↗
  • Mar 2, 26Sell$351KKevin Patrick MoranSVP, CFO & Treasurer↗
  • Feb 23, 26Sell$241KTage Honore↗
  • Aug 7, 25Buy$42KMihael Hristos PolymeropoulosPresident and CEO↗
  • Jun 13, 25Sell$32KStephen Ray Mitchell↗
  • May 21, 25Buy$42KMihael Hristos PolymeropoulosPresident and CEO↗
  • May 21, 25Buy$2KMihael Hristos PolymeropoulosPresident and CEO↗
  • May 16, 25Buy$84KMihael Hristos PolymeropoulosPresident and CEO↗
  • Mar 6, 25Buy$25KMihael Hristos PolymeropoulosPresident and CEO↗

There are 4 more transactions in this stretch.

Stock compensation, tax and giftsshow the 24 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jun 4, 26Compensationamount n/aStephen Ray Mitchell↗
  • Jun 4, 26Compensationamount n/aTage Honore↗
  • Jun 4, 26Compensationamount n/aAnne Sempowski Ward↗
  • Jun 4, 26Compensationamount n/aRICHARD W DUGAN↗
  • Jun 4, 26Compensationamount n/aCharles Cliff Duncan↗
  • Jun 4, 26Compensationamount n/aPhaedra Chrousos↗
  • Jun 4, 26Compensationamount n/aDaniel Patrick McGuireSVP, GC and Secretary↗
  • May 18, 26Giftamount n/aStephen Ray Mitchell↗
  • Apr 22, 26Compensationamount n/aCharles Cliff Duncan↗
  • Feb 18, 26Compensationamount n/aMihael Hristos PolymeropoulosPresident and CEO↗
  • Feb 18, 26Compensationamount n/aKevin Patrick MoranSVP, CFO & Treasurer↗
  • Feb 18, 26Compensationamount n/aTimothy WilliamsSVP & General Counsel↗
  • Feb 18, 26Compensationamount n/aGunther BirznieksSVP, Business Development↗
  • Feb 18, 26Compensationamount n/aJoakim WijkstromSVP, Chief Marketing Officer↗
  • Jun 5, 25Compensationamount n/aAnne Sempowski Ward↗
  • Jun 5, 25Compensationamount n/aTage Honore↗
  • Jun 5, 25Compensationamount n/aRICHARD W DUGAN↗
  • Jun 5, 25Compensationamount n/aPhaedra Chrousos↗
  • Jun 5, 25Compensationamount n/aStephen Ray Mitchell↗
  • Mar 1, 25Tax$128KTimothy WilliamsSVP & General Counsel↗
  • Mar 1, 25Tax$128KKevin Patrick MoranSVP, CFO & Treasurer↗
  • Mar 1, 25Tax$457KMihael Hristos PolymeropoulosPresident and CEO↗
  • Mar 1, 25Tax$128KGunther BirznieksSVP, Business Development↗
  • Mar 1, 25Tax$74KJoakim WijkstromSVP, Chief Marketing Officer↗

The full record holds 100 transactions and goes back to Feb 16, 23.

Its sector and its market

Vanda Pharmaceuticals Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Vanda Pharmaceuticals Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Vanda Pharmaceuticals Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
1,259 documents on file, from Apr 12, 2006 to Oct 9, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.